Proactiveinvestors recommends
Additional Information
Market: AIM
Sector: Food Producers
EPIC: PURE
Latest Price: 93.50p  (0.54% Ascending)
52-week High: 178.50p
52-week Low: 77.50p
Market Cap: 14.44M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Purecircle
www.purecircle.com
The development and manufacture of natural food ingredients for supply to the global food and beverage industry with a current focus in the production and sale of extracted natural high intensity sweetener.
Full Purecircle profile here
Pdf

PureCircle gets US FDA green light for new high purity sweetener

21st Jul 2010, 3:48 pm PureCircle gets US FDA green light for new high purity sweetener

PureCircle (LON:PURE) said its latest natural high purity sweetener, SG95, has received a ‘No Objection letter’ from the US Food and Drug Administration (FDA)  for its use as a food and beverage ingredient in the United States. The company said SG95 will enable it to offer a wider and more flexible array of stevia products, and it will help to further accelerate stevia adoption in the important US market. 

“The launch of SG95 is a very exciting development for PureCircle in the United States with considerable future potential in global markets,” PureCircle CEO & MD Magomet Malsagov said.  

“Expanded use of sweet glycosides from the stevia plant in a highly consistent blend provides both formulation and economic benefits to our customers ... SG95 will provide an additional compelling product in many applications.”

According to PureCircle, the new high purity sweetener delivers great taste and consistency as well as pricing well below sugar. “The product is ideally suited for applications formulated with both sugar and SG95 to achieve a low cost solution to partial sugar and calorie reduction and provide further incentive to application development.”

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.